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Interaction of ligands with the antigen receptor on B lymphocytes leads to a rapid 
and  dramatic series of surface and cytoplasmic events that have been  mostly 
studied using as a probe anti-immunoglobulin (Ig) antibodies (anti-Ig) in murine 
lymphocytes. Four separate but overlapping events can be identified as occurring 
during capping: (a) an initial formation of aggregates of variable sizes on the cell 
surface,  which  is  temperature  but  not  energy dependent  (1,  2);  (b)  a  rapid 
distribution  of  the  complexes  into  a  single  aggregate  or  cap  (3,  4);  (c)  the 
stimulation of translational motility of the cell ¢5); and (d) the internalization of 
the  aggregates  by  pinocytosis  with  subsequent  partial  degradation  of  the 
complexes  (3,  6).  These  latter three  events are  both temperature and  energy 
dependent. There is general agreement that capping results from the interaction 
of a critical amount of cross-linking, bivalent anti-Ig with surface Ig and that it 
involves an energy-dependent step not directly associated with the translation of 
the cell. We have recently discussed the possibility that movement of complexes 
on the cell surface may be brought about by some form of cell surface "activity," 
perhaps in the form of "waves" or "membrane flow" (5).  This activity directed 
towards one zone of the cell surface moves the aggregates of complexes initially 
distributed at random into one lattice forming the cap. This putative "surface 
activity" can be separated from the actual process of movement of the cell on a 
solid surface, since by several experimental maneuvers capping can be induced in 
the absence of actual translation (5).  However, it should be clearly pointed out 
that an association also exists between the surface activity involved in transla- 
tion  and  capping.  It  was  shown  both  in  the  neutrophil  polymorphonuclear 
leukocyte (PMN) ~  (7) and in the lymphocytes that movement serves to direct the 
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cap to the trailing part of the cell. In the lymphocytes, the caps in stationary cells 
occupy a large area of the cell surface, while those in cells in translation are tight 
and occupy a  small area at the posterior part of the cell (5). 
Several recent publications implicate microtubular proteins as exerting some 
form of control of events occurring at the cell surface, including capping. Berlin 
and  co-workers  (8  10)  based  their  conclusions  on  experiments  in  which  the 
relationship between two surface sites was altered by colchicine treatment of the 
cells.  In  a  normal state,  the two sites were discriminated;  but after colchicine 
treatment,  the  sites  were  randomized.  One  of us  (Karnovsky),  together with 
Berlin  and  associates,  observed  that  the  mobility  of Con  A-binding  sites  in 
SV40-transfbrmed  fibroblasts  was  enhanced  by  colehicine  treatment  (11). 
Edelman and co-workers (12-15) inhibited capping of Ig on lymphocytes by con- 
eanavalin A (Con A) treatment at physiological temperatures. The inhibition by 
Con A of Ig capping was counteracted, and capping was obtained, by colchicine 
treatment or by initial reactions with the ligands at low temperatures with sub- 
sequent warming of the labeled cells (12-15). Similar results have been seen in the 
PMN where high concentrations of Con A inhibited capping (7). However, in the 
PMN it was noted that the colchicine effect was not observed on cells in which 
cell movement was inhibited. Hence, the question was raised as to whether the 
colchicine effect of reversing Con A inhibition of capping was mediated through 
cell movement itself, particularly in view of the observation that cell movement in 
itself would apparently favor capping of both monovalent and multivalent ligands, 
apparently through a  sweeping of the label to the trailing edge of the cell (7). 
In  view  of the  above observations,  it  was  of interest  to  re-examine similar 
phenomena  as  they  occur  in  lymphocytes.  We  now  report  on  a  series  of 
experiments on  capping  of Ig-anti-Ig  complexes on  lymphocytes in  which the 
effects  of drugs  that  bind  to  microtubular  protein  have  been  analyzed.  The 
murine lymphocyte is an ideal cell for studying behavior of surface molecules: the 
end point (capping) is very distinct and can be easily scored; and the relationship 
between a stationary cell or one in motion can be reasonably well established by 
scoring  for  the  presence  of  motile  or  ameboid  forms  (5).  One  problem  with 
capping in lymphocytes is its rapidity, but this problem can, in part, be obviated 
by reducing temperature of the test system from 37°C to 21°C. 
Previous  experiments  had  indicated  that  colehicine-treated  lymphocytes 
capped complexes of Ig-anti-Ig without any apparent difficulty (3,  16).  We now 
report that  colchicine has  a  synergistic negative effect with cytochalasin B  on 
capping and that the effect of colchicine on the Con A inhibition of capping can 
be  explained by increased motility of the cell.  All these experiments could be 
interpreted as supporting the hypothesis that microtubules have some effect in 
regulating the surface activity generated by complexing of receptors with their 
ligand,  but  call  attention  to cell  motility as  an  important  factor to take  into 
consideration,  at  least  in  some  systems,  whenever  interpreting  the  role  of 
intracellular organelles in surface behavior. 
Materials  and  Methods 
Cells.  Lymphocytes were harvested from spleens of A/St mice (West Seneca Laboratories, 
Buffalo, N. Y.) by conventional  procedures.  Cells were harvested  using Hanks' balanced salt solution EMIL  R.  UNANUE  AND  MORRIS J.  KARNOVSKY  1209 
(HBSS)  containing  10  mM  HEPES,  and  1%  fetal  calf serum.  After  harvesting,  the  cells were 
centrifuged on a Ficoll-Hypaque gradient in order to eliminate dead cells, erythrocytes, and debris. 
Reagents 
CULTURE MEDIA.  HBSS  with  10  mM  HEPES  and  1%  fetal  calf  serum  were  used  in  most 
experiments. 
FLUORESCENT ANTI-IG ANTIBODY.  It  was  an  IgG  from  polyvalent  rabbit  antimouse  Ig  with  a 
fluorescein (FITC)-protein molar ratio of 4.20-100 t~g were used per test. 
FERRITIN-LABELED ANTI-1G ANTIBODY.  The same IgG as described above was conjugated to ferritin. 
It was the same preparation used by Unanue et al. (4). 
COLCHIClNE.  Colchicine (Sigma Chemical Co.,  St.  Louis,  Mo.)  solutions of 10-4-10 -~ M  were 
prepared immediately before use. 
VINBLASTINE.  Vinblastine (Sigma Chemical Co.) was used at a concentration of 10  '  M. 
CYTOCHALAS|N B.  Cytochalasin B,  (ICI  Research  Laboratories,  Cheshire, England)  a  1  or  10 
ttg/ml solution was prepared in dimethylsulfoxide. 
CON h.  Con A (Miles Laboratories, Inc., Miles Research Div., Kankakee, Ill.), was kept sterile at 
room temperature and used at concentrations of 1-100  ttg/ml. 
Experimental Procedures.  The basic design was to determine the effect of the various drugs on 
the capping of fluorescent anti-Ig-lg complexes. The assays were usually carried out on 2-cm diameter 
flat-bottomed culture dishes (Multi Dish Disposo-Tray, Linbro Chemical Co., New Haven, Conn.). 
0.5  ml  of a  cell  suspension (10Vml)  was  incubated with  anti-Ig either  at  21°C  or  at  37°C.  At 
appropriate times, usually 30 min at 21 °C or 10 min at 37 °C, the reaction was stopped by the addition 
of an equal volume of 2% paraformaldehyde. The cells were left 15 min in the fixative, washed once, 
resuspended in media, and examined under the fluorescent microscope. Cells were scored for those 
showing fluorescence distributed in  caps or throughout the whole cell surface; in the latter case, 
attention was  paid  to  the pattern of fluorescence, whether delicately speckled, forming a  finely 
interrupted ring at the periphery, or coarsely aggregated into patches. 200-300  cells were scored in 
each experiment. 
One set of experiments evaluated the effects of colchicine or cytochalasin B, or both, on capping. In 
these experiment, the cell suspension was first incubated with the drug for 30 min to 2 h; then anti-Ig 
was added, and the reaction was allowed to proceed. The concentration of colchicine was 10 _4 M in 
most experiments. Cytochalasin B was used at 1-10 ttg  ×  ml. 
Most of the experiments using Con A followed the original protocol of Yahara and Edelman (12). 
The cells were incubated with Con A for a period of 30 min before addition of anti-Ig. If necessary, 
colchicine, vinblastine, or cytochalasin B were added together with Con A. 
Results 
Effects o[ Colchicine  and Cytochalasin B.  We studied the effects of colchicine 
or cytochalasin B, or both, on capping of Ig-anti-Ig complexes. Colchicine did not 
interfere with capping of Ig, either at 21°C  or at 37°C,  in accordance with past 
results  (5,  16). In the present experiments, the tempo of capping was evaluated 
by counting caps at different times from 10-30 min at 21°C  in the presence or 
absence of the drug. In normal cells, the rate of capping was markedly reduced at 
21°C  as compared with 37°C, and hence it was possible that effects of any drug 
could be observed better under conditions of reduced temperature. The results of 
Table I clearly indicate no effect of colchicine on the rate of capping. The time of 
incubation of the lymphocytes in 10 .4 M  colchicine was varied from 30 min to 2 h 
and was found not to affect the capping of anti-Ig complexes (results not shown). 
The effects of colchicine were also tested on cells in suspension or settled on a 
dish.  Previous  studies  indicated  that  lymphocytes  settled  on  a  dish  showed 
translational motility upon interaction with a bivalent anti-Ig. This motility was 1210  MOVEMENT  OF  MEMBRANE  ANTIGENS.  V 
reduced in cells in suspension, at least as judged by the presence or absence of 
ameboid forms (5). It was possible that a role of microtubules in capping could be 
evident in  cells  in  suspension,  that  is,  in  conditions where  the  cells were not 
involved in translation. 
Spleen cells were harvested and incubated at 4°C with anti-Ig, washed,  and 
resuspended on a  dish at  10Vml or maintained in suspension (at 108/ml)  for 30 
min at room temperature. Under each condition, cells were suspended in media 
with or without 10 -4 M  colchicine. Colchicine had no effect on capping in cells 
settled on a dish or in suspension, despite the fact that translational motility was 
known to be reduced in the last condition (5). 
Incubation of lymphocytes at 37°C with cytochalasin B did not interfere with 
capping except for the changes already described in previous papers (5). These 
TABLE I 
Effect of Colchicine on Capping at 2I°C 
Time of incubation 
Cells incubated with: 
Regular media  10- ~  M  colchicine 
min  %  % 
5  19.5  16.3 
15  36.8  41.2 
30  80.6  88.2 
Cells were incubated with 10 -~ M  colchicine at room temperature for 30 min before the addition of 
FITC-labeled anti-Ig. 
are  the  appearance of caps  occupying a  large  area  of the  cell  surface, with a 
tendency  for  the  complexes  to  separate  into  loose,  individual  aggregates. 
However, at  21°C,  the  number of caps  in  the  presence of cytochalasin B  was 
reduced  usually  about  30%;  the  cells  not  showing  caps  had  large  masses  of 
complexes in various areas of the membrane. 
There was a  marked reduction in capping by the exposure of lymphocytes to 
both colchicine and cytochalasin B but only when the experiments were done at 
21°C.  At  37°C,  these  effects  were  minimal.  Fig.  1  and  Table  II  depicts 
representative experiments. 
Effects  of  Con A.  Following the  original  protocol of Yahara  and  Edelman 
(12),  we found an  inhibition of Con A  on the capping of Ig-anti-Ig (Table III). 
Patching of the  complexes, as  assayed by fluorescent and electron microscopy 
(using ferritin-labeled anti-Ig in thin sections or freeze etching), was also greatly 
inhibited. The inhibition of capping was best seen in lymphocytes incubated at 
210C with Con A; at 37°C, the inhibitory effects were present, albeit to a lesser 
extent (Table III,  exp.  2).  In agreement with the observation of Edelman and 
co-workers,  we  found  that  drugs  that  bind  to  microtubular  proteins,  like 
colchicine or vinblastine, reversed the inhibition (Table III, exps. 2, 3, and 4). It 
became  very  apparent,  however,  that  the  caps  seen  in  Con  A-treated  cells 
(treated or not treated with colchicine) were distinctly different from the caps EMIL R. UNANUE  AND  MORRIS J. KARNOVSKY  1211 
seen in normal lymphocytes. The caps in Con A-treated cells occupied a larger 
area of the surface, the fluorescence was finely stippled, and, moreover, the caps 
were  generally observed  in  lymphocytes having  ameboid  or  motile forms.  By 
electron microscopy, the complexes in the capping area were evenly distributed 
and showed little aggregation or patching. 
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Fla.  1.  Lymphocytes were  incubated with  the drugs for 30  min before  addition of anti-Ig. 
Colchicine was used at 10 -4 M. Cytochalasin B  (cyto B) was used at 1 ug/ml. 
TABLE II 
Effects of Colchicine and Cytochalasin B on Capping 
Treatment 
Caps at: 
21°C  37°C 
%  % 
Regular media  81.1  93.5 
Colchicine (10  ' M)  82.0  93.0 
Cytochalasin B ( 1 ug/ml.)  64.6  78.6 
Colchicine (10 -' M) plus cytochalasin B  46.5  92.1 
(1 ug/ml.) 
The lymphocytes were incubated with the drugs for 30 min at 21°C or 37°C, anti-Ig was then added, 
and capping allowed to proceed for 30 min at 21°C or for 20 rain at 37°C. 
In the experiment of Fig. 2,  we scored the caps on the basis of the area of the 
lymphocyte that they occupied; that is to say, whether they covered one-fourth, 
one-half,  or  three-fourths  of  the  cell  surface.  Previously,  we  showed  that 
stationary lymphocytes tended to have larger caps (i.e., those occupying one-half 
to  three-fourths  of their  surface),  while  motile  lymphocytes had  small  caps 
occupying a  small  area  (one-fourth caps).  In  this  experiment,  we  allowed  the 
lymphocytes to settle on a dish, carried out the reaction, i.e. added Con A, then 
anti-Ig, and then stopped the reaction with fixative, and then scored the caps. TABLE III 
Inhibition of Capping by Con A 
Dose of Con A  Other treatment  Temperature  Caps 
II 
Ill 
IV 
ug/ml  % 
No Con A  None  21°C  97.1 
1  None  21 °C  94.5 
5  None  21°C  36.5 
10  None  21 °C  25.6 
50  None  21 °C  22.0 
100  None  21 °C  14.3 
No Con A  None  21°C  87.7 
100  None  21 °C  19.5 
100  Colchicine  10-* M*  21°C  65.9 
100  VinbIastine 10  4 M*  21°C  65.3 
No Con A  None  37°C  93.0 
100  None  37 °C  62.8 
No Con A  None  21 °C  87.7 
100  None  21 °C  19.5 
100  Colchicine  10- 4 M*  21 °C  65.9 
None  None  21°C  74.0 
100  None  21°C  36.0 
100  Colchicine  10  4 M*  21°C  58.0 
100  Colehicine  10  * MS  21°C  62.0 
The lymphocytes were incubated with Con A 30 min before the addition  of anti-Ig. 
* Drug was added together with Con A 
$ Lymphocytes were incubated with colchicine 30 min before incubation with Con A. 
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FIG.  2.  This figure  shows the  number of lymphocytes having caps  of different  sizes.  Most 
untreated lymphocytes have small tight caps occupying one-fourth of the cell surface. The caps 
seen in Con A-treated lymphocytes occupy a  much larger area of the surface. 
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Note that while mos.t normal lymphocytes had tight (one-fourth) caps, the great 
number of caps in Con A-treated lymphocytes occupied half or more of the cell 
surface. 
It was of interest to note that Con A-treated lymphocytes containing caps of 
Ig-anti-Ig exhibited very abnormal shapes, being irregularly long and stretched. 
Fig. 3 is a  scanning electron micrograph of one such cell. In the experiment of 
Table IV, we incubated cells with Con A, with or without colchicine, for 30 min, 
then added  FITC  anti-Ig for  30  min,  and  fixed. The  cells  were  examined for 
presence of Ig-anti-Ig in caps or over the entire surface and/or for the presence of 
normal or ameboid shapes. One can note that Con A-treated cells had a reduced 
Fro. 3.  Scanning electron micrograph oflymphocytes  treated with Con A and anti-Ig under the 
conditions described in the text. Note the markedly elongated hand-mirror form of the cell. 
One pole is smooth; the other (presumably the tail) is roughened. ×  14,000. 
TABLE IV 
Motile and Stationary Lymphocytes in the Con A  Effect 
Anti-Ig plus:  Capped lymphocytes  Noncapped lymphocytes 
Con A  Colchicine  %  Round  Ameboid Ratio (ameboid:  %  Round  Ameboid 
round) 
No  No  60  23  37  1.6  40  39  1 
No  10  4  M  63  21  42  2.0  37  37  0 
100 #g  No  20  1  19  19.0  80  76  4 
100#g  10-'M  47  5  42  8.4  53  51  2 
Stationary and ameboid lymphocytes were judged on the basis of morphology (5). 1214  MOVEMENT  OF MEMBRANE  ANTIGENS.  V 
number of caps. Indeed, most caps in Con A lymphocytes were in ameboid cells. 
Colchicine increased the number of caps in Con A-treated lymphocytes increasing 
the number of cells with ameboid features (Fig. 4). 
We  investigated  the  relationship  between  cell  motility  and  the  Con  A 
inhibition of capping by examining microscopically live lymphocytes settled on 
culture dishes. This was done by examining the dishes on an inverted microscope 
either at room temperature or at 37°C with the aid of an air-curtain incubator. 
FIG. 4.  Scanning electron  micrograph of lymphocytes  treated  with Con  A,  colchicine,  and 
anti-Ig.  Note  the  markedly  elongated form.  One  pole  is smooth and shows  blebbing of the 
surface membrane; the other (presumably the tail)  is roughened.  ×  10,000. 
Most normal lymphocytes were round and did not  move. Addition to them of 
anti-Ig produced an increase in random translation in about one-tburth of the 
cells. This translational process,  previously described  (5),  is slow and random. 
Addition of Con  A  produced  a  striking series  of changes.  Some  cells  became 
elongated and very stretched, very slowly displacing themselves. (Some of these 
elongated forms were rather striking; note the scanning electron mierograph in 
Figs. 3 and 4.) After about 5 min, these ameboid lymphoeytes no longer moved, 
although retaining their abnormal shapes. These ameboid shapes persisted for at 
least  2  h  of culture,  suggesting  that  the  lymphocytes were  "frozen" in  their 
peculiar  morphology.  (In  contrast,  normal  lymphocytes  treated  with  anti-Ig 
displaced  themselves for about 20  min and then became round.) The addition 
of  eolchicine  plus  Con  A  brought  about  one  significant  change  from  Con 
A  alone,  and  that  was  that  the  lymphocytes  having  the  ameboid  shapes EMIL  R.  UNANUE AND  MORRIS J.  KARNOVSKY  1215 
continued their slow migration and change of shape for up to 30 min of culture at 
which time they stopped but retained their abnormal morphology. Cytochalasin 
B  (1  ~g/ml)  added  at  the  same  time with  Con  A,  or  Con  A  and  colchicine, 
inhibited all  cell  motility and  development of ameboid shapes  in the lympho- 
cytes. 
In  contrast  to  its  effects on  normal  lymphocytes, cytochalasin B  markedly 
affected  capping  in  Con  A-treated  cells.  First,  cytochalasin  B  enhanced  the 
inhibition of capping produced by Con A; secondly, it counteracted the effect of 
colchicine on the Con A inhibition of capping. These experiments are depicted in 
Table V and Fig. 5. 
We were interested in determining whether the inhibition of Con A on capping 
TABLE V 
Effects of Colchicine and Cytochalasin B  on the 
Inhibition of Capping  by Con A 
Con A  Colchicine  Cytochalasin B  Caps 
ug/ml  ug/ml  % 
No  No  No  56.5 
100  No  No  25.2 
100  10- 4  M  No  53.9 
100  No  1.0  2.0 
100  10  "M  1.0  1.0 
No  No  1.0  41.7 
No  10  4  M  1.0  24.8 
Lymphocytes were incubated with the different drugs for 30 min at 21°C before addition of anti-Ig. 
could be influenced if the lymphocytes were on a solid substrate or in suspension. 
Lymphocytes were  placed  in  a  small  culture  flask  at  room temperature and 
maintained in rotation for the whole time of the experiment. Another portion of 
cells was placed on a culture dish. Both sets were exposed to the drugs for 1 h at 
room temperature, then FITC anti-Ig was added, and the reaction stopped after 
30  min.  The results  of one  representative experiment are  depicted in  Fig.  6. 
Capping was inhibited in lymphocytes placed on a culture dish and treated with 
Con  A;  the  effect  was  reversed  by  colchicine  treatment;  cytochalasin  B 
counteracted the effects of colchicine and enhanced the inhibition produced by 
Con A.  Lymphocytes in suspension and treated with Con A exhibited as many 
caps as normal cells; these lymphocytes with caps were also markedly ameboid, 
and the caps occupied a large area of the surface. We surmised that in suspension 
the  lymphocytes treated with  Con A  could still  produce the changes in shape 
which,  as  discussed  before, were  not  always  associated  with  movement.  The 
capping of these cells, however, was totally inhibited by addition of cytochalasin 
B which also inhibited the changes in cell shape. 1216  MOVEMENT  OF  MEMBRANE  ANTIGENS.  V 
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FIG.  5.  Lymphoeytes were  incubated  with  the  drugs  for  30  min before  addition  of Con  A. 
Colchicine was used at 10  * M, cytochalasin B (cyto B) at 1 #g/ml, and Con A at 100 #g/ml. 
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Fro. 6.  The description of the experiment is in the text. The concentrations of the drug as in 
the experiment of Fig. 5.  Cells were shaken on a  rotating platform at about 150 cycles/min. 
Discussion 
Several results emerge from these experiments, and tentative conclusions can be 
drawn;  however,  it is  fully realized that the great problem in interpreting the 
results  of these  experiments and  others like them is  that they depend on the 
actions of various chemicals, whose specificity of action is not altogether clear, 
and which may also have several sites of interaction with the cell. Cytochalasin B EMIL  R.  UNANUE  AND  MORRIS  J.  KARNOVSKY  1217 
is a drug that clearly inhibits movement, but its site of action is controversial; we 
have accepted the notion that in a broad sense it acts on contractile proteins and 
microfilaments, although other effects, such as inhibition of glucose transport, 
have been indicated (17). Colchicine and similar drugs definitely have specificity 
binding to microtubular protein, but other effects such as inhibition of nucleotide 
transport  (18) have  been  reported.  Apart  from  these  problems,  we  face  the 
general  observation  that  microtubules  and  microfilaments  are  not  seen  in 
abundance  in  B  lymphocytes.  Whether  or  not  colchicine-sensitive and  cyto- 
chalasin B-sensitive structures in the B cells are organized as in other cells needs 
to be determined, as does their pattern of response to these drugs. 
The movement of surface complexes into a cap involves an energy-dependent 
process  and  is  not  the  result  of simple  diffusion. It  is  our  hypothesis that  a 
cross-linking ligand initiates a  series of reactions that result in a  rapid flow of 
membrane producing the cap, and in the stimulation of the translation of the cell 
if it happens to sit on a solid substrate. Basically, capping involves a membrane 
perturbation  that  needs  some  directional  control  for orienting the  complexes 
towards a  focal point. Indeed, as one analyzes the different experiments, they 
strongly suggest that the energy-dependent membrane activity that results  in 
capping is directly or indirectly influenced or regulated by two interrelated but 
distinct internal events, one related to cell translation involving microfilaments, 
i.e., to a cytochalasin B-sensitive system; the other associated with the activation 
of the microtubular system. This statement is based on the fact that the chain of 
events can be stopped at certain steps by appropriate drugs. What is the role of 
microtubules in  these  processes?  This  point  is  not clear,  although the overall 
evidence, albeit indirect, suggests that they do play a role perhaps by orienting 
the membrane activity. There is no doubt that colchicine-treated lymphocytes 
capped Ig and moved, perhaps even more than normal cells. This clearly implies 
that microtubules are not essential in the translational process of the lympho- 
cyte, although the possibility of involvement of some long-lived colchicine-resist- 
ant structure has not been ruled out. Also the kind of movement in the normal 
and colchicine-treated lymphocyte has not been studied in depth, and qualita- 
tive  differences have  not  been  explored.  The  effects of microtubules became 
noticeable in conditions where the actual translation of the cell was stopped, such 
as by cytochalasin B. (There is an apparent discrepancy between this experiment 
and  that  in  which  colchicine-treated lymphocytes in  suspension  still  capped 
despite  the  absence  of  ameboid  forms  indicative  of  cell  translocation.  We 
conclude that in  the  latter instance the  mechanisms subserving translocation 
were operative despite the lack of movement since the cells were not attached to a 
substrate.)  Our  conclusion  is  that  in  a  normal  lymphocyte the  process  of 
translation orients the cap towards its trailing portion, microtubules most likely, 
although not necessarily, playing a role. If, however, translation event is stopped 
at  some  critical  step  in  its  triggering,  such  as  by  cytochalasin B,  then  the 
microtubular system becomes more essential, serving in some way to direct the 
flow of complexes. The important point that we are stressing here is the need for 
some  internal  regulating  process  in  orienting  the  flow  of  complexes.  The 
experiments of Berlin and co-workers (8-11)  in the neutrophil and macrophage 
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do the present experiments with lymphocytes. Likewise, the experiments of Ryan 
et al. (7)  in the neutrophil very clearly demonstrate the role of translation in the 
orientation of the capped complexes. 
The interrelationship between microtubules and surface Ig has been stressed 
by Yahara and Edelman (12-15) in a series of experiments confirmed herein. The 
basic observation is that Con A stops both membrane aggregation of complexes 
and capping and that colchicine counteracts these effects. Edelman's work calls 
attention to two states of microtubules with the possibility of their activation of 
fixation when  Con  A  binds  to the  membrane.  We  interpret these results  in a 
different  way  based  on  the  present  experiments.  Our  indications  are  that 
colchicine is allowing the Con A-treated lymphocyte to increase its translational 
process as  a  result of which  there is  a  backflow of the  complexes to the most 
posterior part of the cell. It appears that  Con A at the doses employed among 
other things restricts the translation of the cell, although these do develop very 
abnormal shapes. This restriction seems to be alleviated by certain maneuvers, 
such  as  treating  the  cell  with  colchicine,  increasing  the  temperature  of the 
reactions (Table  III),  or placing  the  cells  in  suspension  (Fig.  6).  The point to 
stress is  that capping in the Con A lymphocyte, treated or not with colchicine, 
appears to be dependent on movement or at least on a  cytochalasin B-sensitive 
system, which is not the case in the normal cells. Still, the basic effect of Con A 
on the membrane seems to us to be its "stabilization", leading to the blocking of 
patching  or  aggregation.  This  effect was  not  counteracted by  colchicine  (our 
• cytological observations; experiment of Fig. 2). The nature of the Con A effect on 
membrane remains a fascinating point to explore. 
Summary 
Capping of surface Ig by anti-Ig antibodies involves a  membrane perturbation 
requiring  an  energy-dependent  step.  Lymphocytes  treated  with  anti-Ig  are 
stimulated to move. Previously, we had shown that movement was not essential 
for  capping,  although  it  influenced  the  localization  of  the  cap.  We  have 
investigated  the  role  of cell  movement  and  of microtubular  proteins  in  this 
phenomenon.  Treatment  of  B  lymphocytes  with  colchicine  does  not  affect 
capping of Ig nor does it affect the increase in translational movement produced 
by  anti-Ig  antibodies.  Treatment  of  lymphocytes with  cytochalasin  B  stops 
translational movement and may affect capping to some degree under appropri- 
ate  circumstances.  Lymphocytes  treated  with  both  drugs  are  impaired  in 
capping.  We  surmise  that  there  may  be  two  cytoplasmic  events  regulating 
directly or indirectly capping:  one associated with the  process of translational 
movement, the other associated with the activity of microtubules. Lymphocytes 
treated with concanavalin A  do not cap Ig. Colchicine reverses this  inhibition. 
Certain  experimental  procedures  antagonize  the  colchicine  effect,  the  most 
striking of which  is  the  use  of cytochalasin B.  Colchicine appears to increase 
movement  of  the  Con  A-treated  lymphocyte,  and  this  increased  movement 
appears responsible for the accumulation of complexes to the posterior part of the EMIL  R.  UNANUE  AND  MORRIS  J.  KARNOVSKY  1219 
cell.  Con  A  inhibits  patching  of  Ig  by  anti-Ig,  and  this  is  not  reversed  by 
colchicine. 
Received for publication 5 June 1974. 
Note Added in Proof.  After this manuscript was submitted for publication,  a  paper 
by Dr.  S.  de  Petris  appeared  in  Nature (Lond.).  (250:54,  1974), containing experiments 
very similar  to  ours.  de  Petris  presented  data  showing that  both  colchicine and  cyto- 
chalasin B inhibited capping of Ig-anti-Ig and that cytochalasin B had a marked inhibitory 
effect on capping of' FITC-Con A. 
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